After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce ...
People using weight-loss injections are being warned of potential side effects that could impact their ability to drive ...
Glenmark launches Empagliflozin and combinations in India under Glempa brand, aiming to improve glycemic control and reduce ...
A MUM’S bid to reclaim her pre-baby body by using a ‘£90 skinny jab’ nearly killed her – after she collapsed vomiting blood. Gill Riley began using GLP-1-class weight loss ...
Very few people are currently being prescribed drugs for weight loss on the NHS in Scotland, research by BBC Scotland News ...
Hims & Hers Health ( HIMS -15.90%) has been a top healthcare stock to own over the past five years, soaring by around 350% ...
Nanexa AB announces today that the first patient has been dosed in the 30 mg dose group in the ongoing Phase I study with NEX-22, the company's one-month formulation of liraglutide. The ongoing Phase ...
Pharma group Hikma looks to take advantage as Novo Nordisk’s Wegovy and Ozempic start to go off patent next year ...
The global anorexiant market is set for significant expansion, with a projected compound annual growth rate (CAGR) of 5.1% over the forecast period, according to a recent study by Future Market ...